Perioperative management of rheumatoid medications in orthopedic surgery

Orthopedics

Volumn 40, Issue 5, 2017, Pages 282-286

  Sindhu, Kunal ^a   Cohen, Brian ^a   Gil, Joseph A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANAKINRA; CELECOXIB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT;

DISABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNE RESPONSE; INFECTION RISK; NONHUMAN; ORTHOPEDIC SPECIALIST; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; REVIEW; RHEUMATOID ARTHRITIS; TOTAL KNEE ARTHROPLASTY; WOUND HEALING IMPAIRMENT; INFECTION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RISK FACTOR; WOUND HEALING;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INFECTION; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; WOUND HEALING;

EID: 85032225508     PISSN: 01477447     EISSN: 19382367     Source Type: Journal    
DOI: 10.3928/01477447-20170518-04     Document Type: Review

References (37)

1. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006; 36(3):182-188.
2. Saleh KJ, Kurdi AJ, El-Othmani MM, et al. Perioperative treatment of patients with rheumatoid arthritis. J Am Acad Orthop Surg. 2015; 23(9):e38-e48.
3. Goodman SM. Rheumatoid arthritis: perioperative management of biologics and DMARDs. Semin Arthritis Rheum. 2015; 44(6):627-632.
4. Krause ML, Matteson EL. Perioperative management of the patient with rheumatoid arthritis. World J Orthop. 2014; 5(3):283-291.
5. Meune C, Touzé E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2009; 48(10):1309-1313.
6. Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol. 2012; 8(1):32-41.
7. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52(2):402-411.
8. Goodman SM. Rheumatoid arthritis: preoperative evaluation for total hip and total knee replacement surgery. J Clin Rheumatol. 2013; 19(4):187-192.
9. Collins DN, Barnes CL, FitzRandolph RL. Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res. 1991; 272:127-135.
10. Lee JK, Choi CH. Total knee arthroplasty in rheumatoid arthritis. Knee Surg Relat Res. 2012; 24(1):1-6.
11. Wasserman BR, Moskovich R, Razi AE. Rheumatoid arthritis of the cervical spine: clinical considerations. Bull NYU Hosp Jt Dis. 2011; 69(2):136-148.
12. Jacobs AM. Perioperative management of the patient with rheumatoid arthritis. Clin Podiatr Med Surg. 2010; 27(2):235-242.
13. Howe CR, Gardner GC, Kadel NJ. Perioperative medication management for the patient with rheumatoid arthritis. J Am Acad Orthop Surg. 2006; 14(9):544-551.
14. Shourt CA, Crowson CS, Gabriel SE, Matteson EL. Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality. J Rheumatol. 2012; 39(3):481-485.
15. Caplan L, Wolfe F, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol. 2007; 34(4):696-705.
16. Härle P, Straub RH, Fleck M. Perioperative management of immunosuppression in rheumatic diseases: what to do? Rheumatol Int. 2010; 30(8):999-1004.
17. Kehlet H, Binder C. Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J. 1973; 2(5859):147-149.
18. Goodman SM, Ramsden-Stein DN, Huang WT, et al. Patients with rheumatoid arthritis are more likely to have pain and poor function after total hip replacements than patients with osteoarthritis. J Rheumatol. 2014; 41(9):1774-1780.
19. Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012; 64(5):625-639.
20. Scherrer CB, Mannion AF, Kyburz D, Vogt M, Kramers-de Quervain IA. Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs. Arthritis Care Res (Hoboken). 2013; 65(12):2032-2040.
21. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001; 60(3):214-217.
22. Scanzello CR, Figgie MP, Nestor BJ, Goodman SM. Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J. 2006; 2(2):141-147.
23. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998; 101(5):1163-1174.
24. Bibbo C. Wound healing complications and infection following surgery for rheumatoid arthritis. Foot Ankle Clin. 2007; 12(3):509-524.
25. Escalante A, Beardmore TD. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis. J Rheumatol. 1995; 22(10):1844-1851.
26. den Broeder AA, Creemers MC, Fransen J, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2007; 34(4):689-695.
27. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S. Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis. J Clin Rheumatol. 2003; 9(2):115-118.
28. Fuerst M, Möhl H, Baumgärtel K, Rüther W. Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Rheumatol Int. 2006; 26(12):1138-1142.
29. Müller M, Pippi-Ludwig W. Perioperative management of patients with rheumatoid arthritis [in German]. Anaesthesist. 2014; 63(11):883-894.
30. Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011; 70(5):785-791.
31. Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011; 21(5):469-475.
32. Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol. 2013; 40(5):617-623.
33. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008; 59(6):762-784.
34. Ledingham J, Deighton C, British Society for Rheumatology Standards, Guidelines and Audit Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford). 2005; 44(2):157-163.
35. Goodman SM. Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management. Drugs Aging. 2015; 32(5):361-369.
36. Barnard AR, Regan M, Burke FD, Chung KC, Wilgis EF. Wound healing with medications for rheumatoid arthritis in hand surgery. ISRN Rheumatol. 2012; 2012:251962.
37. Mushtaq S, Goodman SM, Scanzello CR. Perioperative management of biologic agents used in treatment of rheumatoid arthritis. Am J Ther. 2011; 18(5):426-434.